Development and screening of contrast agents for in vivo imaging of Parkinson's disease

Invention Grant

US09242015B2 Development and screening of contrast agents for in vivo imaging of Parkinson's disease 有权

Title translation: 开发和筛选用于帕金森病体内成像的造影剂

Patent Title: Development and screening of contrast agents for in vivo imaging of Parkinson's disease
Patent Title (中): 开发和筛选用于帕金森病体内成像的造影剂
Application No.: US13882997

Application Date: 2011-11-11
Publication No.: US09242015B2

Publication Date: 2016-01-26
Inventor: Brian Bacskai
Applicant: Brian Bacskai
Applicant Address: US MA Boston
Assignee: The General Hospital Corporation
Current Assignee: The General Hospital Corporation
Current Assignee Address: US MA Boston
Agency: Nixon Peabody LLP
International Application: PCT/US2011/060340 WO 20111111
International Announcement: WO2012/065045 WO 20120518
Main IPC: A61K49/00
IPC: A61K49/00 ; A61K51/04 ; G01N33/68 ; A61B5/00

Abstract:

The invention provides compounds and a method for imaging aggregated α-synuclein, e.g., Lewy bodies or Lewy neurites, in a tissue or organ.

Abstract(Chinese):

本发明提供化合物和用于在组织或器官中成像聚集的α-突触核蛋白（例如路易体或路易体神经突）的方法。

Public/Granted literature

Information query

Espacenet

IPC分类:

A	人类生活必需
A61	医学或兽医学；卫生学
A61K	医用、牙科用或梳妆用的配制品（专门适用于将药品制成特殊的物理或服用形式的装置或方法A61J3/00；空气除臭，消毒或灭菌，或者绷带、敷料、吸收垫或外科用品的化学方面，或材料的使用入A61L；肥皂组合物入C11D）
A61K49/00	体内试验用的配制品